Full Text View
Tabular View
No Study Results Posted
Related Studies
Cardiotoxicity of Adjuvant Trastuzumab (CATS)
This study is ongoing, but not recruiting participants.
Study NCT00858039   Information provided by Royal Prince Alfred Hospital, Sydney, Australia

First Received on March 6, 2009.   Last Updated on April 14, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Neoplasms
Heart Failure
Additional conditions recognized in this trial
Neoplasms
More general conditions related to this trial
Breast Diseases
Cardiovascular Diseases
Heart Diseases
Neoplasms by Site
Skin Diseases
Additional drug interventions recognized in this trial
Natriuretic Peptide, Brain
Trastuzumab
More general drug interventions related to this trial
Antineoplastic Agents
Cardiovascular Agents
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Royal Prince Alfred Hospital, Sydney, Australia


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services